Back to Agenda
LS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan
Session Chair(s)
Harumasa Nakamura, MD, PHD
Director of Department of Clinical Research Support, , National Center of Neurology and Psychiatry, Japan
Speaker(s)
Mihoko Kobayashi
Japan Development Leader, Clinical Research, Rare Disease, Pfizer R&D Japan, Japan
Atsushi Nishizawa
Head of Plasma-Derived Therapies Strategy Unit, Takeda Pharmaceutical Company Limited, Japan
Kosuke Ito, PHD
Principal Reviewer, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?